Skip to main content
Phase 2 Results: Zerlasiran siRNA Drug Lowers Lp(a) by 90%
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Phase 2 Results: Zerlasiran siRNA Drug Lowers Lp(a) by 90%
User login
Username
Password
Reset your password
Concept
Lead
score
Lipids Management
1
1
Cardiovascular disease
0
0.58
Cardiovascular Risk Management
0
0.58
Genetics
0
0.58
Genomic Medicine
0
0.58
Plasma
0
0.58
Specialty
Lead
score
Cardiology
1
1
Family Medicine/Primary Care
0
0.9
Internal Medicine
0
0.8
Edit Tags